Drug Trial Radar · NCT06471829
A Trial of Lu AG13909 in Adult Participants With Cushing's Disease
Last checked: Nov 19, 2026Latest source record: Oct 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
16
Actual
Start
Jun 19, 2024
Primary completion
Aug 10, 2027
Study completion Oct 31, 2027
Sponsor
- Lead sponsor
- H. Lundbeck A/SIndustry
- Sponsor type
- Industry
- First posted
- Jun 24, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This trial will evaluate the effects of Lu AG13909 in adult participants with Cushing's disease (CD). CD is a rare and serious disorder where the body makes too much of a hormone called cortisol. The main goals of this trial are to learn about 1. the effect of Lu AG13909 on cortisol levels. 2. the safety and tolerability of Lu AG13909. 3. the pharmacokinetic parameters of Lu AG13909 (how the drug is absorbed, distributed, and processed by the body).
Conditions
- Cushing's Disease
Interventions
Lu AG13909Drug
Solution for injection/infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Part A & Part B: Urinary Free Cortisol (UFC) Complete Response: mean UFC (mUFC) ≤ Upper Limit of Normal (ULN) at the end of the IV/SC Titration PeriodTime frame: Up to 490 days
Locations
27 sites in 9 countries. Site status is shown where the registry gives one.
University of Michigan Health-A. Alfred Taubman Health Care Center
Ann Arbor, Michigan
Washington University School of Medicine in St. Louis
St Louis, Missouri
AP-HP - Hôpital Bicêtre
Le Kremlin-Bicêtre, France
Hospices Civils de Lyon (HCL) - Hopital Louis Pradel - Centre De Reference Maladie De Rendu-Osler
Bron, Auvergne-Rhône-Alpes, France
Centre Hospitalier Universitaire de Lille (CHU Lille)
Lille, Hauts-de-France, France
Centre Hospitalier Universitaire de Bordeaux - Hopital Haut-Leveque
Pessac, New Aquitaine, France
Centre Hospitalier Universitaire d'Angers - Centre de recherche clinique
Angers, Pays de la Loire Region, France
Assistance Publique Hopitaux de Marseille (AP-HM) - Hopital de la Conception - Pole Psychiatrie C...
Marseille, Provence-Alpes-Côte d'Azur Region, France
Aversi Clinic - Tbilisi
Tbilisi, Georgia
Multiprofile Clinic - Consilium Medulla
Tbilisi, Georgia
Aversi Clinic - Tbilisi
Tbilisi, Georgia
Semmelweis Egyetem - Belgyogyaszati es Onkologiai Klinika (I.sz. Belgyogyaszati Klinika)
Budapest, Hungary
Pecsi Tudomanyegyetem (PTE) (University of Pecs)
Pécs, Baranya, Hungary
Debreceni Egyetem - Klinikai Kozpont - Onkologiai Klinika
Debrecen, Hajdú-Bihar, Hungary
Azienda Ospedaliera Universitaria "Gaetano Martino" - Messina
Messina, Italy
Universita degli Studi di Padova - Azienda Ospedaliera di Padova - Ospedale Busonera
Padua, Italy
Azienda Ospedaliero Universitaria Pisana - Stabilimento Ospedaliero di Santa Chiara - Istituto To...
Pisa, Italy
Sapienza Universita di Roma - Azienda Ospedaliera Sant Andre
Rome, Italy
Azienda Ospedaliera Universitaria Citta della Salute e della Scienza di Torino - Ospedale Sant'Anna
Turin, Italy
Uniwersytet Jagiellonski Collegium Medicum - Szpital Uniwersytecki w Krakowie - Katedra i Klinika...
Krakow, Lesser Poland Voivodeship, Poland
Institutul National de Endocrinologie "C.I. Parhon"
Bucharest, Romania
Spitalul Clinic Judetean de Urgenta Cluj-Napoca
Cluj-Napoca, Cluj, Romania
Spitalul Clinic Judetean Mures (SCJM)
Târgu Mureş, Mureș County, Romania
Hospital de la Santa Creu I Sant Pau
Barcelona, Spain
Hospital Universitario Ramon y Cajal
Madrid, Spain
Northern Care Alliance NHS Foundation Trust - North Manchester General Hospital
Manchester, Europe, United Kingdom
University of Birmingham - Institute of Metabolism and Systems Research (IMSR)
Birmingham, West Midlands, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.